Adaptive Biotechnologies Corp. (ADPT)
16.68
-0.08
(-0.45%)
USD |
NASDAQ |
Dec 24, 12:59
16.66
-0.02
(-0.09%)
After-Hours: 13:59
Adaptive Biotechnologies SG&A Expense (TTM): 162.86M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.717B |
| Vertex Pharmaceuticals, Inc. | 1.644B |
| Zymeworks, Inc. | 62.27M |
| Cue Biopharma, Inc. | 16.81M |
| Akero Therapeutics, Inc. (DELISTED) | 43.02M |